CN114029012A - Preparation method of microcapsule with metal organic coordination polymer as wall material - Google Patents
Preparation method of microcapsule with metal organic coordination polymer as wall material Download PDFInfo
- Publication number
- CN114029012A CN114029012A CN202110979623.8A CN202110979623A CN114029012A CN 114029012 A CN114029012 A CN 114029012A CN 202110979623 A CN202110979623 A CN 202110979623A CN 114029012 A CN114029012 A CN 114029012A
- Authority
- CN
- China
- Prior art keywords
- anhydrous
- sulfate
- various types
- oil
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 47
- 239000013256 coordination polymer Substances 0.000 title claims abstract description 28
- 229920001795 coordination polymer Polymers 0.000 title claims abstract description 28
- 239000000463 material Substances 0.000 title claims abstract description 20
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 17
- 239000002184 metal Substances 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 31
- 239000004530 micro-emulsion Substances 0.000 claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 14
- 238000001914 filtration Methods 0.000 claims abstract description 13
- 238000005406 washing Methods 0.000 claims abstract description 13
- 229940079593 drug Drugs 0.000 claims abstract description 11
- 239000013110 organic ligand Substances 0.000 claims abstract description 10
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000000839 emulsion Substances 0.000 claims abstract description 6
- 229910021645 metal ion Inorganic materials 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 30
- 238000003756 stirring Methods 0.000 claims description 23
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 15
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 10
- 239000012071 phase Substances 0.000 claims description 9
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 claims description 8
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 8
- 229910000358 iron sulfate Inorganic materials 0.000 claims description 8
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 claims description 8
- MIVBAHRSNUNMPP-UHFFFAOYSA-N manganese(2+);dinitrate Chemical compound [Mn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MIVBAHRSNUNMPP-UHFFFAOYSA-N 0.000 claims description 8
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 claims description 8
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 8
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
- 239000003995 emulsifying agent Substances 0.000 claims description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 claims description 6
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical group CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 6
- PHFQLYPOURZARY-UHFFFAOYSA-N chromium trinitrate Chemical compound [Cr+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O PHFQLYPOURZARY-UHFFFAOYSA-N 0.000 claims description 6
- GRWVQDDAKZFPFI-UHFFFAOYSA-H chromium(III) sulfate Chemical compound [Cr+3].[Cr+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRWVQDDAKZFPFI-UHFFFAOYSA-H 0.000 claims description 6
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 6
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 claims description 6
- 235000002867 manganese chloride Nutrition 0.000 claims description 6
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 claims description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 4
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 4
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 claims description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 4
- 229910021555 Chromium Chloride Inorganic materials 0.000 claims description 4
- 229910021380 Manganese Chloride Inorganic materials 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 4
- 239000005642 Oleic acid Substances 0.000 claims description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 claims description 4
- 229940057499 anhydrous zinc acetate Drugs 0.000 claims description 4
- XZQOHYZUWTWZBL-UHFFFAOYSA-L chromium(ii) bromide Chemical compound [Cr+2].[Br-].[Br-] XZQOHYZUWTWZBL-UHFFFAOYSA-L 0.000 claims description 4
- 229940011182 cobalt acetate Drugs 0.000 claims description 4
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 claims description 4
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 claims description 4
- 229910001981 cobalt nitrate Inorganic materials 0.000 claims description 4
- 229910000361 cobalt sulfate Inorganic materials 0.000 claims description 4
- 229940044175 cobalt sulfate Drugs 0.000 claims description 4
- KTVIXTQDYHMGHF-UHFFFAOYSA-L cobalt(2+) sulfate Chemical compound [Co+2].[O-]S([O-])(=O)=O KTVIXTQDYHMGHF-UHFFFAOYSA-L 0.000 claims description 4
- QAHREYKOYSIQPH-UHFFFAOYSA-L cobalt(II) acetate Chemical compound [Co+2].CC([O-])=O.CC([O-])=O QAHREYKOYSIQPH-UHFFFAOYSA-L 0.000 claims description 4
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 claims description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 claims description 4
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 claims description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 4
- YIXJRHPUWRPCBB-UHFFFAOYSA-N magnesium nitrate Chemical compound [Mg+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O YIXJRHPUWRPCBB-UHFFFAOYSA-N 0.000 claims description 4
- 239000011565 manganese chloride Substances 0.000 claims description 4
- 229940099607 manganese chloride Drugs 0.000 claims description 4
- UOGMEBQRZBEZQT-UHFFFAOYSA-L manganese(2+);diacetate Chemical compound [Mn+2].CC([O-])=O.CC([O-])=O UOGMEBQRZBEZQT-UHFFFAOYSA-L 0.000 claims description 4
- HEYNLDRKZOOEDN-UHFFFAOYSA-L manganese(2+);trifluoromethanesulfonate Chemical compound [Mn+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HEYNLDRKZOOEDN-UHFFFAOYSA-L 0.000 claims description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 claims description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 4
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 claims description 4
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 claims description 4
- KBJMLQFLOWQJNF-UHFFFAOYSA-N nickel(ii) nitrate Chemical compound [Ni+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O KBJMLQFLOWQJNF-UHFFFAOYSA-N 0.000 claims description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 4
- DVMZCYSFPFUKKE-UHFFFAOYSA-K scandium chloride Chemical compound Cl[Sc](Cl)Cl DVMZCYSFPFUKKE-UHFFFAOYSA-K 0.000 claims description 4
- 229910000346 scandium sulfate Inorganic materials 0.000 claims description 4
- DFCYEXJMCFQPPA-UHFFFAOYSA-N scandium(3+);trinitrate Chemical compound [Sc+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O DFCYEXJMCFQPPA-UHFFFAOYSA-N 0.000 claims description 4
- QHYMYKHVGWATOS-UHFFFAOYSA-H scandium(3+);trisulfate Chemical compound [Sc+3].[Sc+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O QHYMYKHVGWATOS-UHFFFAOYSA-H 0.000 claims description 4
- HZXJVDYQRYYYOR-UHFFFAOYSA-K scandium(iii) trifluoromethanesulfonate Chemical compound [Sc+3].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F HZXJVDYQRYYYOR-UHFFFAOYSA-K 0.000 claims description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical group [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 4
- 238000009210 therapy by ultrasound Methods 0.000 claims description 4
- 229940102001 zinc bromide Drugs 0.000 claims description 4
- 235000005074 zinc chloride Nutrition 0.000 claims description 4
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 3
- 229940078552 o-xylene Drugs 0.000 claims description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 3
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 claims description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 claims description 2
- MQRWBMAEBQOWAF-UHFFFAOYSA-N acetic acid;nickel Chemical compound [Ni].CC(O)=O.CC(O)=O MQRWBMAEBQOWAF-UHFFFAOYSA-N 0.000 claims description 2
- ODWXUNBKCRECNW-UHFFFAOYSA-M bromocopper(1+) Chemical compound Br[Cu+] ODWXUNBKCRECNW-UHFFFAOYSA-M 0.000 claims description 2
- RDLMYNHWUFIVQE-UHFFFAOYSA-L cobalt(2+);trifluoromethanesulfonate Chemical compound [Co+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F RDLMYNHWUFIVQE-UHFFFAOYSA-L 0.000 claims description 2
- BZRRQSJJPUGBAA-UHFFFAOYSA-L cobalt(ii) bromide Chemical compound Br[Co]Br BZRRQSJJPUGBAA-UHFFFAOYSA-L 0.000 claims description 2
- SBTSVTLGWRLWOD-UHFFFAOYSA-L copper(ii) triflate Chemical compound [Cu+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F SBTSVTLGWRLWOD-UHFFFAOYSA-L 0.000 claims description 2
- RJYMRRJVDRJMJW-UHFFFAOYSA-L dibromomanganese Chemical compound Br[Mn]Br RJYMRRJVDRJMJW-UHFFFAOYSA-L 0.000 claims description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 2
- GYCHYNMREWYSKH-UHFFFAOYSA-L iron(ii) bromide Chemical compound [Fe+2].[Br-].[Br-] GYCHYNMREWYSKH-UHFFFAOYSA-L 0.000 claims description 2
- 229940071125 manganese acetate Drugs 0.000 claims description 2
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 229940078494 nickel acetate Drugs 0.000 claims description 2
- UQPSGBZICXWIAG-UHFFFAOYSA-L nickel(2+);dibromide;trihydrate Chemical compound O.O.O.Br[Ni]Br UQPSGBZICXWIAG-UHFFFAOYSA-L 0.000 claims description 2
- KVRSDIJOUNNFMZ-UHFFFAOYSA-L nickel(2+);trifluoromethanesulfonate Chemical compound [Ni+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F KVRSDIJOUNNFMZ-UHFFFAOYSA-L 0.000 claims description 2
- AIYYMMQIMJOTBM-UHFFFAOYSA-L nickel(ii) acetate Chemical class [Ni+2].CC([O-])=O.CC([O-])=O AIYYMMQIMJOTBM-UHFFFAOYSA-L 0.000 claims description 2
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 claims description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 2
- 229920000053 polysorbate 80 Polymers 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- APPHYFNIXVIIJR-UHFFFAOYSA-K scandium bromide Chemical compound Br[Sc](Br)Br APPHYFNIXVIIJR-UHFFFAOYSA-K 0.000 claims description 2
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 2
- 235000013904 zinc acetate Nutrition 0.000 claims description 2
- 239000011592 zinc chloride Substances 0.000 claims description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 2
- 229960001763 zinc sulfate Drugs 0.000 claims description 2
- CITILBVTAYEWKR-UHFFFAOYSA-L zinc trifluoromethanesulfonate Substances [Zn+2].[O-]S(=O)(=O)C(F)(F)F.[O-]S(=O)(=O)C(F)(F)F CITILBVTAYEWKR-UHFFFAOYSA-L 0.000 claims description 2
- ZMLPZCGHASSGEA-UHFFFAOYSA-M zinc trifluoromethanesulfonate Chemical compound [Zn+2].[O-]S(=O)(=O)C(F)(F)F ZMLPZCGHASSGEA-UHFFFAOYSA-M 0.000 claims description 2
- DUNKXUFBGCUVQW-UHFFFAOYSA-J zirconium tetrachloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 claims description 2
- 238000002156 mixing Methods 0.000 description 7
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 4
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 4
- 239000007764 o/w emulsion Substances 0.000 description 4
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 4
- 229960001553 phloroglucinol Drugs 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 239000011162 core material Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 230000000087 stabilizing effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 239000007762 w/o emulsion Substances 0.000 description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- -1 phloroglucinol oleic acid Chemical compound 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000011067 sorbitan monolaureate Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
- B01J13/16—Interfacial polymerisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/008—Supramolecular polymers
Abstract
The invention discloses a microcapsule taking a metal organic coordination polymer as a wall material and a preparation method thereof. The preparation method of the microcapsule takes the microemulsion as a template, so that metal ions and phenolic organic ligands are subjected to coordination reaction at an oil-water interface to form a coordination polymer film, and then the microcapsule encapsulated with the medicine is obtained by washing, filtering and collecting. The invention adopts an emulsion interface reaction method to prepare the microcapsule, has simple process and strong universality, and can encapsulate both water-soluble drugs and oil-soluble drugs.
Description
Technical Field
The invention belongs to the technical field of biomedical engineering, medical carriers and membrane engineering, and relates to a microcapsule and a preparation method thereof, in particular to a microcapsule taking a metal organic coordination polymer as a wall material and a preparation method thereof.
Background
The microcapsule technology is a technology in which a solid, liquid or gas is embedded therein using a film-forming material to form a micro capsule having a diameter of several tens of nanometers to several thousands of micrometers, in which the encapsulated substance is referred to as a core material and the substance encapsulating the core material is referred to as a wall material. Because the microcapsule has good effects of protecting, slowly releasing, controlling release, changing form, covering bad smell and the like on the core material, the microcapsule technology is widely applied to a plurality of fields of food, medicine, dye, cosmetics, pesticide, chemical fertilizer and the like.
In recent years, the coordination supermolecule system based on metal ion-tannic acid is a very ideal microcapsule wall material due to the characteristics of rapid coordination reaction, pH responsiveness and the like, and attracts people's attention, for example, CN 110622965A. However, due to the water-soluble characteristics of metal ions and tannic acid, the interfacial polymerization method is difficult to prepare the microcapsule, and the application range of the microcapsule is greatly limited. Therefore, a new coordination system is still needed to be explored, and the preparation materials of the microcapsule are enriched.
Disclosure of Invention
In order to solve the technical problems in the background technology, the invention provides a preparation method of microcapsules taking metal organic coordination polymers as wall materials.
The invention is realized by the following technical scheme:
and taking the microemulsion as a template, and carrying out coordination reaction on metal ions and a phenolic organic ligand at an oil-water interface of the microemulsion to obtain the microcapsule.
The size of the microcapsule obtained by the method is about 10-300 mu m.
The microemulsions are oil-in-water emulsions, or water-in-oil emulsions.
The microemulsion is in a droplet wrapping form, and is an oil-in-water droplet or a water-in-oil droplet, so that an oil-water interface of the microemulsion is spherical.
The preparation method of the microcapsule is slightly different according to different modes of oil-in-water type and water-in-oil type needle micro-emulsion.
And aiming at the oil-in-water microemulsion, slowly adding an aqueous solution containing a metal salt with the concentration of 0.1-100 mM into the oil-in-water microemulsion, reacting at a spherical oil-water interface to form a metal ion-phenol coordination polymer film, and then washing, filtering and collecting to obtain the microcapsule encapsulated with the oil-soluble medicine.
The oil-in-water microemulsion is formed by stirring or swirling or ultrasonic treatment of an aqueous solution containing 0-10 wt% of a hydrophilic emulsifier and an oil phase solution containing 0.1-30 mM of a phenolic organic ligand, a specific drug and an organic solvent, wherein the volume of the aqueous phase is 1.5: 1-20: 1.
Adding an oil phase solution consisting of a phenolic organic ligand and an organic solvent with the concentration of 0.1-30 mM into the water-in-oil microemulsion, reacting at a spherical oil-water interface to form a metal ion-phenolic coordination polymer film, and then washing, filtering and collecting to obtain the microcapsule encapsulated with the water-soluble drug.
The water-in-oil microemulsion is formed by stirring or swirling or ultrasonic treatment of an oil phase solution containing a lipophilic emulsifier with a concentration of 0-10 wt% and an aqueous phase solution containing a metal salt with a concentration of 0.1-30 mM, a specific drug and water, wherein the volume of the aqueous phase to the volume of the oil phase is 1: 1.5-1: 20.
The hydrophilic emulsifier is one or more of polyvinyl alcohol (PVA), polyvinylpyrrolidone, sodium dodecyl sulfate, tween 20, tween 80 and triton 100.
Preferably, the lipophilic emulsifier is one or more of span 80 and span 20.
The phenolic organic ligand is one or two of the following molecular structures:
wherein A is one of-CHO, -CH ═ N-OH.
The metal salt is silver nitrate, anhydrous copper chloride, various hydrated copper chlorides, anhydrous copper sulfate, various hydrated copper sulfates, anhydrous copper nitrate, various hydrated copper nitrates, copper trifluoromethanesulfonate, anhydrous copper acetate, various hydrated copper acetates, copper bromide, anhydrous nickel chloride, various hydrated nickel chlorides, anhydrous nickel sulfate, various hydrated nickel sulfates, anhydrous nickel nitrate, various hydrated nickel nitrates, nickel trifluoromethanesulfonate, anhydrous nickel acetate, various hydrated nickel acetates, nickel bromide, anhydrous zinc chloride, various hydrated zinc chlorides, anhydrous zinc sulfate, various hydrated zinc sulfates, anhydrous zinc nitrate, various hydrated zinc nitrates, zinc trifluoromethanesulfonate, anhydrous zinc acetate, various hydrated zinc acetates, zinc bromide, anhydrous manganese chloride, anhydrous manganese sulfate, anhydrous manganese nitrate, various hydrated manganese nitrates, manganese trifluoromethanesulfonate, anhydrous zinc sulfate, anhydrous zinc acetate, anhydrous zinc bromide, anhydrous manganese chloride, various hydrated manganese chlorides, anhydrous manganese sulfate, anhydrous manganese nitrate, various hydrated manganese nitrate, manganese trifluoromethanesulfonate, anhydrous copper sulfate, anhydrous copper chloride, anhydrous copper sulfate, anhydrous nickel sulfate, anhydrous zinc nitrate, anhydrous zinc sulfate, anhydrous magnesium nitrate, anhydrous magnesium sulfate, anhydrous magnesium sulfate, magnesium sulfate, Anhydrous manganese acetate, hydrous manganese acetates of various types, manganese bromide, anhydrous cobalt chloride, hydrous cobalt chloride of various types, anhydrous cobalt sulfate, hydrous cobalt sulfate of various types, anhydrous cobalt nitrate, hydrous cobalt nitrate of various types, cobalt trifluoromethanesulfonate, anhydrous cobalt acetate, hydrous cobalt acetate of various types, cobalt bromide, anhydrous scandium chloride of various types, hydrous scandium chloride of various types, anhydrous scandium sulfate, hydrous scandium sulfate of various types, scandium trifluoromethanesulfonate, anhydrous scandium nitrate, hydrous scandium nitrate of various types, anhydrous iron chloride of various types, hydrous iron chloride of various types, scandium bromide, anhydrous iron sulfate, iron sulfate of various types, anhydrous iron acetate, hydrous iron acetate of various types, iron bromide, anhydrous iron sulfate of various types, hydrous iron sulfate of various types, titanium tetrachloride, zirconium tetrachloride, platinum chloride, chromium chloride, hydrous chromium chloride of various types, chromium bromide, hydrous chromium bromide of various types, chromium sulfate of various types, anhydrous chromium nitrate of various types, One or more of various hydrated chromium nitrates, chromium chlorides, various hydrated chromium chlorides, chromium sulfates and various hydrated chromium sulfates.
The organic solvent is one or more of oleic acid, ethanol, ethyl acetate, methyl acetate, toluene, o-xylene, mesitylene, dichloromethane, chloroform, dimethyl carbonate, n-hexane, n-heptane, n-pentane, methyl tert-butyl ether, n-butyl ether, isobutyl ether, n-hexanol and ISOPAR series solvents.
The medicine comprises vitamin A, insulin, essence, nicotinamide and the like, but is not limited to the vitamin A, the insulin, the essence, the nicotinamide and the like.
The preparation method of the microcapsule takes the microemulsion as a template, so that metal ions and phenolic organic ligands are subjected to coordination reaction at an oil-water interface to form a coordination polymer film, and then the microcapsule encapsulated with the medicine is obtained by washing, filtering and collecting.
The invention has the beneficial effects that:
compared with the prior art, the separation membrane with high separation selectivity is prepared by an interface coordination self-assembly technology; the preparation method is simple, the operation is easy, and the industrial practicability is good.
The invention adopts an emulsion interface reaction method to prepare the microcapsule, has simple process and strong universality, can encapsulate both water-soluble drugs and oil-soluble drugs, realizes the slow release of the drugs and improves the utilization efficiency of the drugs; moreover, the metal-phenol microcapsule material is low in price and has no obvious toxic and side effects.
Drawings
FIG. 1 is a microscopic image of the microcapsule obtained in example 1.
Detailed Description
The invention is further described with reference to the accompanying drawings and the detailed description.
The examples of the invention are as follows:
example 1
Uniformly mixing 1 wt% PVA aqueous solution and 5mM o-xylene solution of trialdehyde phloroglucinol at a ratio of 5: 1 under stirring to form an oil-in-water emulsion, and slowly adding a certain amount of 5mM FeCl under the condition of continuous stirring3And (3) the solution initiates the oil-water interface of the microemulsion to perform coordination reaction to form a coordination polymer film, and after the solution is stabilized for 3min, the stirring is stopped, and the microcapsule is obtained by washing and filtering.
Example 2
A1 wt% span 80 solution in dichloromethane and 2mM FeCl3And (3) uniformly stirring and mixing the solution according to a ratio of 5: 1 by magnetic force to form a water-in-oil emulsion, slowly adding a certain amount of dichloromethane solution of 5mM trialdehyde phloroglucinol under the condition of continuous stirring to initiate the oil-water interface of the microemulsion to perform coordination reaction to form a coordination polymer film, stopping stirring after stabilizing for 3min, washing and filtering to obtain the microcapsule.
Example 3
Mixing 1 wt% Tween 20 water solution and 2mM trialdehyde phloroglucinol oleic acid solution at a ratio of 3: 1 under stirring to form oil-in-water emulsion, and slowly adding 1mM FeCl3And (3) the solution initiates the oil-water interface of the microemulsion to perform coordination reaction to form a coordination polymer film, and after the solution is stabilized for 3min, the stirring is stopped, and the microcapsule is obtained by washing and filtering.
Example 4
A0.5 wt% solution of span 80 in n-butyl ether and 2mM Fe (NO)3)3Stirring and mixing the solution uniformly according to the ratio of 10: 1 to form a water-in-oil emulsion, slowly adding a certain amount of n-butyl ether solution of 5mM2,4, 6-trihydroxybenzene-1, 3, 5-benzene trioxymethylene under the condition of continuously stirring to initiate the oil-water interface of the microemulsion to perform coordination reaction to form a coordination polymer film, stabilizing for 5min, stopping stirring, washing and filtering to obtain the microcapsule.
Example 5
Uniformly mixing 5 wt% PVA water solution and 2mM trialdehyde phloroglucinol oleic acid solution according to a ratio of 5: 1 under stirring to form an oil-in-water emulsion, and slowly adding a certain amount of 1mM CuCl under the condition of continuously stirring2And (3) the solution initiates the oil-water interface of the microemulsion to perform coordination reaction to form a coordination polymer film, and after the solution is stabilized for 3min, the stirring is stopped, and the microcapsule is obtained by washing and filtering.
Example 6
Mixing 2 wt% PVA water solution and oleic acid solution containing 3mM trialdehyde phloroglucinol and vitamin A medicine at a ratio of 4: 1 under stirring to form oil-in-water emulsion, and slowly adding a certain amount of 1mM CuCl under stirring2The solution initiates the oil-water interface of the microemulsion to generate coordination reaction to form a coordination polymer film, after the solution is stabilized for 3min, the stirring is stopped, and the microcapsule is obtained by washing and filtering, as shown in figure 1.
Example 7
0.5 wt% span 80 in oleic acid was mixed with 2mM FeCl3And uniformly mixing the micro-emulsion and an aqueous solution of an insulin medicament by magnetic stirring at a ratio of 5: 1 to form a water-in-oil emulsion, slowly adding a certain amount of dichloromethane solution of 5mM trialdehyde phloroglucinol under the condition of continuous stirring to initiate the oil-water interface of the micro-emulsion to perform coordination reaction to form a coordination polymer film, stopping stirring after stabilizing for 3min, washing and filtering to obtain the microcapsule, wherein the formula is shown in figure 1.
Claims (10)
1. A method for preparing microcapsules by taking metal organic coordination polymers as wall materials is characterized in that: and taking the microemulsion as a template, and carrying out coordination reaction on metal ions and a phenolic organic ligand at an oil-water interface of the microemulsion to obtain the microcapsule.
2. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 1, wherein the method comprises the following steps: the microemulsions are oil-in-water emulsions, or water-in-oil emulsions.
3. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 1 or 2, wherein: and adding an aqueous solution containing metal salt with the concentration of 0.1-100 mM into the oil-in-water microemulsion aiming at the oil-in-water microemulsion, reacting at an oil-water interface to form a metal ion-phenol coordination polymer film, and then washing, filtering and collecting to obtain the microcapsule encapsulated with the oil-soluble medicine.
4. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 3, wherein the method comprises the following steps: the oil-in-water microemulsion is formed by stirring or swirling or ultrasonic treatment of an aqueous solution containing 0-10 wt% of a hydrophilic emulsifier and an oil phase solution containing 0.1-30 mM of a phenolic organic ligand, a drug and an organic solvent, wherein the volume of the aqueous phase to the volume of the oil phase is 1.5: 1-20: 1.
5. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 1 or 2, wherein: adding an oil phase solution consisting of a phenol organic ligand and an organic solvent with the concentration of 0.1-30 mM into the water-in-oil microemulsion, reacting at an oil-water interface to form a metal ion-phenol coordination polymer film, and then washing, filtering and collecting to obtain the microcapsule encapsulated with the water-soluble medicine.
6. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 5, wherein the method comprises the following steps: the water-in-oil microemulsion is formed by stirring or swirling or ultrasonic treatment of an oil phase solution containing a lipophilic emulsifier with a concentration of 0-10 wt% and an aqueous phase solution containing a metal salt with a concentration of 0.1-30 mM, a drug and water, wherein the volume of the aqueous phase to the volume of the oil phase is 1: 1.5-1: 20.
7. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 4, wherein the method comprises the following steps: the hydrophilic emulsifier is one or more of polyvinyl alcohol (PVA), polyvinylpyrrolidone, sodium dodecyl sulfate, tween 20, tween 80 and triton 100.
9. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 3 or 6, wherein: the metal salt is silver nitrate, anhydrous copper chloride, various hydrated copper chlorides, anhydrous copper sulfate, various hydrated copper sulfates, anhydrous copper nitrate, various hydrated copper nitrates, copper trifluoromethanesulfonate, anhydrous copper acetate, various hydrated copper acetates, copper bromide, anhydrous nickel chloride, various hydrated nickel chlorides, anhydrous nickel sulfate, various hydrated nickel sulfates, anhydrous nickel nitrate, various hydrated nickel nitrates, nickel trifluoromethanesulfonate, anhydrous nickel acetate, various hydrated nickel acetates, nickel bromide, anhydrous zinc chloride, various hydrated zinc chlorides, anhydrous zinc sulfate, various hydrated zinc sulfates, anhydrous zinc nitrate, various hydrated zinc nitrates, zinc trifluoromethanesulfonate, anhydrous zinc acetate, various hydrated zinc acetates, zinc bromide, anhydrous manganese chloride, anhydrous manganese sulfate, anhydrous manganese nitrate, various hydrated manganese nitrates, manganese trifluoromethanesulfonate, anhydrous zinc sulfate, anhydrous zinc acetate, anhydrous zinc bromide, anhydrous manganese chloride, various hydrated manganese chlorides, anhydrous manganese sulfate, anhydrous manganese nitrate, various hydrated manganese nitrate, manganese trifluoromethanesulfonate, anhydrous copper sulfate, anhydrous copper chloride, anhydrous copper sulfate, anhydrous nickel sulfate, anhydrous zinc nitrate, anhydrous zinc sulfate, anhydrous magnesium nitrate, anhydrous magnesium sulfate, anhydrous magnesium sulfate, magnesium sulfate, Anhydrous manganese acetate, hydrous manganese acetates of various types, manganese bromide, anhydrous cobalt chloride, hydrous cobalt chloride of various types, anhydrous cobalt sulfate, hydrous cobalt sulfate of various types, anhydrous cobalt nitrate, hydrous cobalt nitrate of various types, cobalt trifluoromethanesulfonate, anhydrous cobalt acetate, hydrous cobalt acetate of various types, cobalt bromide, anhydrous scandium chloride of various types, hydrous scandium chloride of various types, anhydrous scandium sulfate, hydrous scandium sulfate of various types, scandium trifluoromethanesulfonate, anhydrous scandium nitrate, hydrous scandium nitrate of various types, anhydrous iron chloride of various types, hydrous iron chloride of various types, scandium bromide, anhydrous iron sulfate, iron sulfate of various types, anhydrous iron acetate, hydrous iron acetate of various types, iron bromide, anhydrous iron sulfate of various types, hydrous iron sulfate of various types, titanium tetrachloride, zirconium tetrachloride, platinum chloride, chromium chloride, hydrous chromium chloride of various types, chromium bromide, hydrous chromium bromide of various types, chromium sulfate of various types, anhydrous chromium nitrate of various types, One or more of various hydrated chromium nitrates, chromium chlorides, various hydrated chromium chlorides, chromium sulfates and various hydrated chromium sulfates.
10. The method for preparing microcapsules using metal-organic coordination polymers as wall materials according to claim 4 or 5, wherein: the organic solvent is one or more of oleic acid, ethanol, ethyl acetate, methyl acetate, toluene, o-xylene, mesitylene, dichloromethane, chloroform, dimethyl carbonate, n-hexane, n-heptane, n-pentane, methyl tert-butyl ether, n-butyl ether, isobutyl ether, n-hexanol and ISOPAR series solvents.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110979623.8A CN114029012A (en) | 2021-08-25 | 2021-08-25 | Preparation method of microcapsule with metal organic coordination polymer as wall material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110979623.8A CN114029012A (en) | 2021-08-25 | 2021-08-25 | Preparation method of microcapsule with metal organic coordination polymer as wall material |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114029012A true CN114029012A (en) | 2022-02-11 |
Family
ID=80140062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110979623.8A Pending CN114029012A (en) | 2021-08-25 | 2021-08-25 | Preparation method of microcapsule with metal organic coordination polymer as wall material |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114029012A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115404048A (en) * | 2022-09-21 | 2022-11-29 | 东南大学 | Composite phase change energy storage material and preparation method thereof |
CN115418503A (en) * | 2022-08-23 | 2022-12-02 | 成都先进金属材料产业技术研究院股份有限公司 | Method for selectively extracting scandium from leachate based on microemulsion |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085754A (en) * | 2015-08-04 | 2015-11-25 | 东华大学 | Microcapsule with poly butanediol dimethylacrylate as wall material and preparing method of microcapsule |
CN105080445A (en) * | 2015-09-14 | 2015-11-25 | 哈尔滨工业大学 | Method for preparing microcapsule with tannic acid-ferric ion polymer serving as wall material by taking micro emulsion as template by interface reaction |
CN106221674A (en) * | 2016-07-14 | 2016-12-14 | 中国矿业大学 | A kind of inorganic hydrous salt phase transition microcapsule energy storage material and preparation method |
CN110721644A (en) * | 2019-10-22 | 2020-01-24 | 北京理工大学 | Radiation preparation method of vinyl polymer microcapsule |
-
2021
- 2021-08-25 CN CN202110979623.8A patent/CN114029012A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105085754A (en) * | 2015-08-04 | 2015-11-25 | 东华大学 | Microcapsule with poly butanediol dimethylacrylate as wall material and preparing method of microcapsule |
CN105080445A (en) * | 2015-09-14 | 2015-11-25 | 哈尔滨工业大学 | Method for preparing microcapsule with tannic acid-ferric ion polymer serving as wall material by taking micro emulsion as template by interface reaction |
CN106221674A (en) * | 2016-07-14 | 2016-12-14 | 中国矿业大学 | A kind of inorganic hydrous salt phase transition microcapsule energy storage material and preparation method |
CN110721644A (en) * | 2019-10-22 | 2020-01-24 | 北京理工大学 | Radiation preparation method of vinyl polymer microcapsule |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115418503A (en) * | 2022-08-23 | 2022-12-02 | 成都先进金属材料产业技术研究院股份有限公司 | Method for selectively extracting scandium from leachate based on microemulsion |
CN115404048A (en) * | 2022-09-21 | 2022-11-29 | 东南大学 | Composite phase change energy storage material and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114029012A (en) | Preparation method of microcapsule with metal organic coordination polymer as wall material | |
CA2050911C (en) | Encapsulation process and products therefrom | |
Chen et al. | Simple and continuous fabrication of self-propelled micromotors with photocatalytic metal–organic frameworks for enhanced synergistic environmental remediation | |
EP0285694B1 (en) | Porous polymeric beads for the delivery of an active ingredient | |
US5132117A (en) | Aqueous core microcapsules and method for their preparation | |
Liu et al. | Preparation of uniform-sized multiple emulsions and micro/nano particulates for drug delivery by membrane emulsification | |
US5093198A (en) | Adjuvant-enhanced sustained release composition and method for making | |
EP0141584B1 (en) | Durable controlled release microcapsules | |
CN102349871B (en) | Nano-micro drug delivery system and preparation method of 10-hydroxyl camptothecin | |
Xu et al. | Synthesis of Au and Pt hollow capsules with single holes via pickering emulsion strategy | |
Zhu et al. | Rapid production of single-and multi-compartment polymeric microcapsules in a facile 3D microfluidic process for magnetic separation and synergistic delivery | |
CN104688714A (en) | Graphene/ chitosan compound micro-capsule and preparation method thereof | |
CN101168196A (en) | Method for preparing nickel-base amorphous nano particles | |
CN103113515B (en) | A kind of magnetic porous polymer beads and preparation method thereof | |
Liu et al. | Efficient fabrication of polymer shell colloidosomes by a spray drying process | |
Wang et al. | Stimuli responsiveness, propulsion and application of the stimuli-responsive polymer based micromotor | |
CN110961055B (en) | Ionic liquid polymeric microspheres and preparation method and application thereof | |
SK et al. | Use of microencapsulation in textiles | |
Dai et al. | Preparation and characterization of fine silver powder with colloidal emulsion aphrons | |
Zhang et al. | Pickering emulsion stabilized by temperature-sensitive PS@ PNIPA nanoparticles as microcontainers | |
CN103111208B (en) | A kind of solid suspension list distribution emulsion and emulsification method thereof | |
JP4272372B2 (en) | Microcapsule and manufacturing method thereof | |
CN105394032A (en) | Preparation method of methyl parathion microcapsules | |
CN111330574A (en) | Method for preparing core-shell cerium-gold catalyst by reverse microemulsion method and application of catalyst | |
CN112430335B (en) | Structure-controllable anisotropic polymer microsphere and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |